论文

[1]Shi L, Yuan H, Xu J, Long J, Liu F, Jin Y, Chen S, Zhu J, Duan G, Yang H*. The longitudinal trend and driving factors of antimicrobial resistance among Streptococcus pneumoniae worldwide. Int J Antimicrob Agents. 2025 Feb;65(2):107415.

[2]Cui W, Liang X, Xiao W, Wang Y, Liu F, Chen S, Long J, Jin Y, Duan G, Yang H*. The role and mechanism of efflux pump norB in biofilm formation of Staphylococcus aureus. Gene. 2025 Feb 5;936:149105.

[3]Yuan H, Xu J, Wang Y, Shi L, Dong Y, Liu F, Long J, Duan G, Jin Y, Chen S, Zhu J, Yang H*.The longitudinal trend and influential factors exploring of global antimicrobial resistance in Klebsiella pneumoniae. Sci Total Environ. 2024 Nov 10;950:175357.

[4]Wang J, Li X, Du X, Jia H, Chen H, Wu J, Duan G, Yang H*, Wang L*. Unveiling the drivers of vancomycin-resistant enterococcus in China: A comprehensive ecological study. Infect Med (Beijing). 2024 Dec 21;4(1):100159.

[5]Xu J, Wang Y, Duan G, Liu F, Yang H*. Impact of non-pharmaceutical interventions during COVID-19 pandemic on measles and mumps in Mainland China. J Infect. 2023 Mar; 86(3): 256-308.

[6]Xu J, Wang Y, Liu F, Yang H*. Changes of tuberculosis infection in mainland China before and after the COVID-19 pandemic. J Infect. 2023 Feb; 86(2): 154-225.

[7]Wang Y, Wang Y, Duan G, Yang H*. NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis. J Hepatol. 2023 Apr; 78(4): e136-e139.

[8]Wang Y, Hu M, Yang H*. Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data. J Hepatol. 2023 Jan; 78(1): e28-e31.

[9]Yang H*, Xu J, Shi L, Duan G, Wang Y. Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'. Ann Rheum Dis. 2023 Apr; 82(4): e79.

[10]Yuan H, Liu F, Long J, Duan G, Yang H*. A review on circular RNAs and bacterial infections. Int J Biol Macromol. 2023 Jul 31; 244: 125391.

[11]Zheng P, Liu F, Long J, Jin Y, Chen S, Duan G, Yang H*. Latest Advances in the Application of Humanized Mouse Model for Staphylococcus aureus. J Infect Dis. 2023 Sep 15; 228(6): 800-809.

[12]Xu J, Wang Y, Liu F, Duan G, Yang H*. Genome mining reveals the prevalence and extensive diversity of toxin-antitoxin systems inStaphylococcus aureus. Front Microbiol. 2023 May 24; 14: 1165981.

[13]Wang Y, Zhang P, Wu J, Chen S, Jin Y, Long J, Duan G, Yang H*. Transmission of livestock-associated methicillin-resistant Staphylococcus aureus between animals, environment, and humans in the farm. Environ Sci Pollut Res Int. 2023 Aug; 30(37): 86521-86539.

[14]Han X, Xu J, Hou H, Yang H*, Wang Y. Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis. J Infect. 2022 Mar; 84(3): 418-467.

[15]Wang Y, Liang X, Xu J, Nan L, Liu F, Duan G, Yang H*. Rapid and Ultrasensitive Detection of Methicillin-Resistant Staphylococcus aureus Based on CRISPR-Cas12a Combined With Recombinase-Aided Amplification. Front Microbiol. 2022 Jun 3; 13: 903298.

[16]Yang H*, Hou H, Liang X, Xu J, Wang Y. Lack of significant association between dyslipidemia and COVID-19 mortality. J Infect. 2021 Jun; 82(6): 276-316.

[17]Yang H*, Liang X, Hou H, Xu J, Shi L, Wang Y. The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates. J Infect. 2021 May; 82(5): e6-e10.

[18]Yang H*, Xu J, Liang X, Shi L, Wang Y. Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates. J Infect. 2021 Apr; 82(4): e23-e26.

[19]Hou H, Xu J, Li Y, Wang Y, Yang H*. The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates. J Allergy Clin Immunol Pract. 2021 Nov; 9(11): 3944-3968.

[20]Li Y, Zhang Y, Chen M, Hu J, Zhang H, Xiang Y, Yang H*, Qiu S, Song H. Plasmid-borne colistin resistance gene mcr-1 in a multidrug resistant Salmonella enterica serovar Typhimurium isolate from an infant with acute diarrhea in China. Int J Infect Dis. 2021 Feb; 103: 13-18.

[21]Zhang Y, Liu K, Zhang Z, Tian S, Liu M, Li X, Han Y, Zhu K, Liu H, Yang C, Liu H, Du X, Wang Q, Wang H, Yang M, Wang L, Song H, Yang H*, Xiang Y, Qiu S. A Severe Gastroenteritis Outbreak of Salmonella enterica Serovar Enteritidis Linked to Contaminated Egg Fried Rice, China, 2021. Front Microbiol. 2021 Nov 22; 12: 779749

[22] Wang Y, Mao T, Li Y, Xiao W, Liang X, Duan G, Yang H*. Characterization of 67 Confirmed Clustered Regularly Interspaced Short Palindromic Repeats Loci in 52 Strains of Staphylococci. Front Microbiol. 2021 Oct 22; 12:736565.

[23] Shi L, Xu J, Duan G, Yang H*, Wang Y. The pooled prevalence of pulmonary embolism in patients with COVID-19. Intensive Care Med. 2020 Nov; 46(11): 2089-2091.

[24]Oppong TB, Amponsem-Boateng C, Kyere EKD, Wang Y, Gheisari Z, Oppong EE, Opolot G, Duan G, Yang H*. Infection Prevention and Control Preparedness Level and Associated Determinants in 56 Acute Healthcare Facilities in Ghana. Infect Drug Resist. 2020 Nov 24; 13: 4263-4271.

著作

[1]杨海燕（参编），《流行病学》，国家开放大学出版社，2022

[2]杨海燕（参编），《公共卫生课程思政精品教案集》，郑州大学出版社，2021

[3]杨海燕(参编)，全国高等学校研究生教材《流行病学研究原理与方法》，四川科学技术出版社, 2018

[4]杨海燕(参编)，“十二五”国家级规划教材《流行病学》，中国协和医科大学出版社，2017

[5]杨海燕(参编)，“十二五”规划数字教材《预防医学》，人民卫生出版社，2015

[6]杨海燕(副主编)，《临床科研方法概论》，郑州大学出版社，2008

成果专利

[1]杨海燕(1/10)，新冠肺炎重症化风险识别定量评估及应用，河南省教育厅，科技成果奖，一等奖，2024年

[2]杨海燕(1/10)，肠道致病菌多重耐药分子机制及流行病学研究，河南省医学科技奖，一等奖，2024年

[3]杨海燕(1/10)，新型冠状病毒感染早期流行特征及重症危险因素研究，河南省教育厅，科技成果奖，二等奖，2023年

[4]杨海燕(2/7)，TGIF1在乳腺癌转移中的生物学作用及分子机制研究，河南省医学会，河南省医学科学技术进步奖，二等奖，2022年

[5]杨海燕(2/15)，消毒灭菌与基层医疗机构医院感染预防与控制研究，河南省人民政府，河南省科学技术进步奖，三等奖，2010年

[6]杨海燕(4/15)，志贺菌耐药分子基础研究，河南省卫生厅，河南省医学科学技术进步奖，二等奖，2010年

[7]杨海燕(6/15)，静滴卷曲霉素对复治菌阳肺结核的临床效果及安全性研究，河南省人民政府，河南省科学技术进步奖，二等奖，2006年

[8]杨海燕（1/6)，基于CRISPR的试剂盒及其应用，中国，发明专利号：ZL 202011512116.5

[9]杨海燕（1/6)，基于CRISPR靶点的MRSA菌检测，中国，发明专利号：ZL 202310047377.1